Transcriptional Up-Regulation of FBXW7 by KCa1.1 K+ Channel Inhibition through the Nrf2 Signaling Pathway in Human Prostate Cancer LNCaP Cell Spheroid Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25116019 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Susumu Ohya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan. Hauptthemen laut MEDLINE: F-Box-WD Repeat-Containing Protein 7, NF-E2-Related Factor 2, Prostatic Neoplasms, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, The Salt Science Research Foundation, Japan, JSPS KAKENHI.
Abstract (Originalsprache)
The tumor suppressor gene F-box and WD repeat domain-containing (FBXW) 7 reduces cancer stemness properties by promoting the protein degradation of pluripotent stem cell markers. We recently demonstrated the transcriptional repression of FBXW7 by the three-dimensional (3D) spheroid formation of several cancer cells. In the present study, we found that the transcriptional activity of FBXW7 was promoted by the inhibition of the Ca2+-activated K+ channel, KCa1.1, in a 3D spheroid model of human prostate cancer LNCaP cells through the Akt-Nrf2 signaling pathway. The transcriptional activity of FBXW7 was reduced by the siRNA-mediated inhibition of the CCAAT-enhancer-binding protein C/EBP δ (CEBPD) after the transfection of miR223 mimics in the LNCaP spheroid model, suggesting the transcriptional regulation of FBXW7 through the Akt-Nrf2-CEBPD-miR223 transcriptional axis in the LNCaP spheroid model. Furthermore, the KCa1.1 inhibition-induced activation of FBXW7 reduced (1) KCa1.1 activity and protein levels in the plasma membrane and (2) the protein level of the cancer stem cell (CSC) markers, c-Myc, which is a molecule degraded by FBXW7, in the LNCaP spheroid model, indicating that KCa1.1 inhibition-induced FBXW7 activation suppressed CSC conversion in KCa1.1-positive cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.
ORCID-Profile: Susumu Ohya, Junko Kajikuri
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- The Salt Science Research Foundation, Japan
- JSPS KAKENHI
- The Salt Science Research Foundation
Zitieren
APA
Ohya, S., Kito, H., Kajikuri, J., Yamaguchi, Y., & Matsui, M. (2024). Transcriptional Up-Regulation of FBXW7 by KCa1.1 K+ Channel Inhibition through the Nrf2 Signaling Pathway in Human Prostate Cancer LNCaP Cell Spheroid Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116019
Vancouver
Ohya S, Kito H, Kajikuri J, Yamaguchi Y, Matsui M. Transcriptional Up-Regulation of FBXW7 by KCa1.1 K+ Channel Inhibition through the Nrf2 Signaling Pathway in Human Prostate Cancer LNCaP Cell Spheroid Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116019
BibTeX
@article{Ohya2024,
author = {Ohya, Susumu and Kito, Hiroaki and Kajikuri, Junko and Yamaguchi, Yohei and Matsui, Miki},
title = {Transcriptional Up-Regulation of FBXW7 by KCa1.1 K+ Channel Inhibition through the Nrf2 Signaling Pathway in Human Prostate Cancer LNCaP Cell Spheroid Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25116019}
}
EUVIMED